NCT04654689 - Impact of the Combined Treatment of Liposomed Polyphenols With G04CB02 on the ALS Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 20, 2021

Primary Completion Date

November 12, 2022

Study Completion Date

February 4, 2023

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DIETARY_SUPPLEMENT

Liposomed polyphenols resveratrol and curcumin

Combination of resveratrol (75mg) and curcumin (200mg) liposomed

OTHER

Placebo for liposomed resveratrol and curcumin

Water with sucrose replacing the liposomed polyphenols

DIETARY_SUPPLEMENT

Isocaloric Diet

40% carbohydrates, 40% lipids and 20% proteins

DRUG

G04CB02

G04CB02, in a single daily dose for 2 months

OTHER

Placebo microcrystalline methylcellulose

Placebo replacing G04CB02

Trial Locations (1)

José Enrique de la Rubia Ortí, Valencia

All Listed Sponsors

lead

Fundación Universidad Católica de Valencia San Vicente Mártir

OTHER